関連する実験動画
Updated: May 5, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
26.7K
多民族集団における肥満のカットポイントを定義する
Fahad Razak1, Sonia S Anand, Harry Shannon
1Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
Circulation
|April 11, 2007
まとめ
肥満のための標準体量指数 (BMI) のカットポイントは,すべての民族集団に適用されない場合があります. この研究では,南アジア人,中国人,および先住民の代謝リスクに対するBMIの値がヨーロッパ人と比較して低いことが判明しました.
科学分野:
- 心臓病学 心臓病学
- エンドクリノロジー エンドクリノロジー
- 人口の健康 人口の健康
背景:
- ボディマス指数 (BMI) は,心血管疾患と2型糖尿病リスクを評価するための一般的な指標です.
- 現在の肥満のカットポイント (BMI>30 kg/m2) は,ヨーロッパの人口に基づいています.
- これらのBMIのカットポイントが非ヨーロッパ人集団に適用できるかどうかは不明である.
研究 の 目的:
- 様々な民族集団におけるBMIに関連した代謝リスクの評価.
- 精密な肥満分類のために,民族特有のBMIカットポイントが必要かどうかを判断する.
主な方法:
- カナダの南アジア,中国,先住民族,欧州の民族集団の参加者1078人を対象とした研究.
- 主要成分因子分析は,14の心代謝マーカーに適用されました.
- 潜在的要因に基づいた民族特有のBMIカットポイントの導出.
主要な成果:
- 3つの潜在的要因が,グルコース,脂質,血圧マーカーの変動の56%を説明しました.
- 南アジア人,中国人,先住民は,ヨーロッパ人と比較して,低BMIでより高い心代謝リスクを示した.
- グルコースおよび脂質因子に基づく肥満のカットポイントは,非ヨーロッパ人グループでは約6kg/m2低かった.
結論:
- 肥満に関する既存のBMIのカットポイントは,南アジア,中国,および先住民の集団では改訂が必要になる可能性があります.
- 修正されたカットポイントの実施は,これらのグループで肥満に関連する代謝障害のより高い流行を明らかにする可能性があります.
関連する概念動画
Quantifying and Rejecting Outliers: The Grubbs Test
4.0K
Sometimes, a data set can have a recorded numerical observation that greatly deviates from the rest of the data. Assuming that the data is normally distributed, a statistical method called the Grubbs test can be used to determine whether the observation is truly an outlier. To perform a two-tailed Grubbs test, first, calculate the absolute difference between the outlier and the mean. Then, calculate the ratio between this difference and the standard deviation of the sample. This...
4.0K
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
Bias in Epidemiological Studies
1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.7K

